MAIA Biotechnology (MAIA) Price to Book (2022 - 2026)

MAIA Biotechnology (MAIA) has reported Price to Book for 5 consecutive years, with 4.24 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Book fell 71.33% year-over-year to 4.24 in Q2 2026; TTM through Jun 2026 was 4.24, a 71.33% decrease from a year earlier, with the FY2025 full-year figure at 20.68, up 45.13% from the prior year.
• Price to Book was 4.24 for Q2 2026 at MAIA Biotechnology, up from 2.28 in the prior quarter.
• Over five years, Price to Book peaked at 1273.21 in Q3 2025 and troughed at 7.85 in Q1 2024.
• A 5-year average of 91.31 and a median of 10.09 in 2023 frame the typical range for Price to Book.
• Across the five-year window, Price to Book plunged 204.93% in 2024 and soared 2960.0% in 2025, its largest moves.
• Over 5 years, Price to Book stood at 4.52 in 2022, then surged by 618.88% to 32.49 in 2023, then tumbled by 56.15% to 14.25 in 2024, then surged by 45.13% to 20.68 in 2025, then tumbled by 79.52% to 4.24 in 2026.
• The last three Price to Book figures came in at 4.24 (Q2 2026), 2.28 (Q1 2026), and 20.68 (Q4 2025), per Business Quant data.